[HTML][HTML] Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology consensus guideline on margins for breast …
M Morrow, KJ Van Zee, LJ Solin, N Houssami… - Annals of surgical …, 2016 - Springer
Purpose Controversy exists regarding the optimal negative margin width for ductal
carcinoma in situ (DCIS) treated with breast-conserving surgery and whole-breast …
carcinoma in situ (DCIS) treated with breast-conserving surgery and whole-breast …
Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry
AM Brewster, M Chavez-MacGregor… - The Lancet Oncology, 2014 - thelancet.com
Breast cancer incidence is increasing worldwide, and breast cancer-related mortality is
highest in women of African ancestry, who are more likely to have basal-like or triple …
highest in women of African ancestry, who are more likely to have basal-like or triple …
Society of Surgical Oncology–American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in …
MS Moran, SJ Schnitt, AE Giuliano, JR Harris… - International Journal of …, 2014 - Elsevier
Purpose To convene a multidisciplinary panel of breast experts to examine the relationship
between margin width and ipsilateral breast tumor recurrence (IBTR) and develop a …
between margin width and ipsilateral breast tumor recurrence (IBTR) and develop a …
Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update.
KH Allison, MEH Hammond, M Dowsett, SE McKernin… - 2020 - repository.icr.ac.uk
Purpose: To update key recommendations of the American Society of Clinical
Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) …
Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) …
[HTML][HTML] Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes …
AS Caudle, WT Yang, S Krishnamurthy… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Purpose Placing clips in nodes with biopsy-confirmed metastasis before initiating
neoadjuvant therapy allows for evaluation of response in breast cancer. Our goal was to …
neoadjuvant therapy allows for evaluation of response in breast cancer. Our goal was to …
[HTML][HTML] Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer
A Melhem-Bertrandt, M Chavez-MacGregor… - Journal of clinical …, 2011 - ncbi.nlm.nih.gov
Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative
Breast Cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Breast Cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer
Importance As the COVID-19 pandemic continues, understanding the clinical outcomes of
patients with cancer and COVID-19 has become critically important. Objective To compare …
patients with cancer and COVID-19 has become critically important. Objective To compare …
[HTML][HTML] DCIS margins and breast conservation: MD Anderson Cancer Center multidisciplinary practice guidelines and outcomes
Recent published guidelines suggest that adequate margins for DCIS should be≥ 2 mm
after breast conserving surgery followed by radiotherapy (RT). Many groups now use this …
after breast conserving surgery followed by radiotherapy (RT). Many groups now use this …
Delayed initiation of adjuvant chemotherapy among patients with breast cancer
M Chavez-MacGregor, CA Clarke… - JAMA …, 2016 - jamanetwork.com
Importance Adjuvant chemotherapy improves outcomes of patients with breast cancer.
However, the optimal timing of chemotherapy initiation is unknown. Delayed administration …
However, the optimal timing of chemotherapy initiation is unknown. Delayed administration …
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
R Aft, M Naughton, K Trinkaus, M Watson… - The lancet …, 2010 - thelancet.com
Background Treatment with bisphosphonates decreases bone loss and can increase
disease-free survival in patients with breast cancer. The aim of our study was to assess the …
disease-free survival in patients with breast cancer. The aim of our study was to assess the …